In silico validation of a new classifier, PCSCG ier, for predicting recurrence‐free survival in prostate cancer patients : Evidence from multiple datasets
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Clinical and Translational Medicine - 13(2023), 1 |
Beteiligte Personen: |
Zhang, Meng [VerfasserIn] |
---|
Anmerkungen: |
© 2023 |
---|
Umfang: |
6 |
---|
doi: |
10.1002/ctm2.1105 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
WLY015429164 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | WLY015429164 | ||
003 | DE-627 | ||
005 | 20231111144117.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231111s2023 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1002/ctm2.1105 |2 doi | |
028 | 5 | 2 | |a 2023-11-11_CTM2_2023_13_1.zip.xml |
035 | |a (DE-627)WLY015429164 | ||
035 | |a (WILEY)CTM21105 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
100 | 1 | |a Zhang, Meng |e verfasserin |4 aut | |
245 | 1 | 0 | |a In silico validation of a new classifier, PCSCG ier, for predicting recurrence‐free survival in prostate cancer patients |b Evidence from multiple datasets |
264 | 1 | |c 2023 | |
300 | |a 6 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © 2023 | ||
700 | 1 | |a Bian, Zichen |4 aut | |
700 | 1 | |a Chen, Jia |4 aut | |
700 | 1 | |a Chen, Lei |4 aut | |
700 | 1 | |a Zhou, Jun |4 aut | |
700 | 1 | |a Niu, Qingsong |4 aut | |
700 | 1 | |a Hao, Zongyao |4 aut | |
700 | 1 | |a Meng, Jialin |4 aut | |
700 | 1 | |a Liang, Chaozhao |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical and Translational Medicine |g 13(2023), 1 |w (DE-627)WLY00437052X |x 20011326 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2023 |g number:1 |g extent:6 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_WLY | ||
951 | |a AR | ||
952 | |d 13 |j 2023 |e 1 |g 6 |